Ontology highlight
ABSTRACT:
SUBMITTER: Copelan EA
PROVIDER: S-EPMC4329042 | biostudies-literature | 2015 Mar
REPOSITORIES: biostudies-literature
Copelan Edward A EA Avalos Belinda R BR Ahn Kwang Woo KW Zhu Xiaochun X Gale Robert Peter RP Grunwald Michael R MR Hamadani Mehdi M Hamilton Betty K BK Hale Gregory A GA Marks David I DI Waller Edmund K EK Savani Bipin N BN Costa Luciano J LJ Ramanathan Muthalagu M Cahn Jean-Yves JY Khoury H Jean HJ Weisdorf Daniel J DJ Inamoto Yoshihiro Y Kamble Rammurti T RT Schouten Harry C HC Wirk Baldeep B Litzow Mark R MR Aljurf Mahmoud D MD van Besien Koen W KW Ustun Celalettin C Bolwell Brian J BJ Bredeson Christopher N CN Fasan Omotayo O Ghosh Nilanjan N Horowitz Mary M MM Arora Mukta M Szer Jeffrey J Loren Alison W AW Alyea Edwin P EP Cortes Jorge J Maziarz Richard T RT Kalaycio Matt E ME Saber Wael W
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20141217 3
Cyclophosphamide (Cy) in combination with busulfan (Bu) or total body irradiation (TBI) is the most commonly used myeloablative conditioning regimen in patients with chronic myeloid leukemia (CML). We used data from the Center for International Bone Marrow Transplantation Research to compare outcomes in adults who underwent hematopoietic cell transplantation for CML in first chronic phase after myeloablative conditioning with Cy in combination with TBI, oral Bu, or intravenous (i.v.) Bu. Four hu ...[more]